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Letters to the Editor 
Dear Editor 
Mechanisms proposed whereby 
/?-blockers might worsen obstructive 
sleep apnoea (OSA) 
Obstructive sleep apnoea (OSA) is a serious breathing 
disorder characterized by repeated collapse of the upper 
airway during sleep leading to asphyxia and arousal. This 
cycle of throat closure, wakening, a few breaths, snoring 
and throat reblockage can occur hundreds of times in the 
night greatly disturbing the sleep of the sufferer and cause 
excessive daytime sleepiness. 
In a recent paper Fletcher (1) reported that hypertension 
is diagnosed in 90% of OSA patients and OSA can be found 
in 3&35X of patients with diagnosed systemic hyperten- 
sion. P-blockers are often the drug of choice to treat 
hypertension in the general population. 
Longstaff (2) reported the sudden nocturnal death of an 
OSA sufferer after 5 weeks on p-blocker medication, during 
which time the deceased had complained of more sleep 
disruptions and constant fatigue. Increased daytime sleepi- 
ness, memory lapses, morning confusion and apnoea were 
witnessed. Two possible mechanisms (C. W. Zwillich, pers. 
comm., 1997) whereby P-blockade might have worsened 
apnoea were invoked: (a) bradycardia associated with 
apnoea may be worse during b-blockade and could lead to 
cardiac arrest and (b) autonomic excitation which occurs 
during hypercapnia and hypoxaemia may be blunted by /3- 
blockade, resulting in altered arousal responses or extreme 
levels of vasodilation, which is usually counter-balanced by 
some adrenergic stimulation during hypercapnia. 
Vanuxem et al. (3) reported impairment of muscle energy 
metabolism in OSA patients which was linked to repeated 
bouts of nocturnal hypoxaemia. These findings may be 
pertinent to this issue, since any further reduction in energy 
to key muscles, as a result of medication, might possibly 
lead to unwelcome consequences in individuals with 
certain heart problems. D. Vanuxem (pers. comm., 1998) 
has acknowledged that P-blockers might interfere with 
energy metabolism to the striated muscles of the upper 
airways and has proposed the following mechanism: in 
muscle metabolism, the activation of phosphorylase kinase 
by cyclic AMP is triggered by epinephrine and therefore can 
at least be partly impaired by /?-blockade. 
According to Peter et al. (4) cardiac arrest is to be 
expected with severe OSA and p-blockers are not used in 
their sleep laboratory. 
The hypothesis that P-blockers might prolong throat 
closure in OSA sufferers would seem to call for an investi- 
gation, using animal models, into the effect of these drugs 
on upper airway muscle metabolism. 
MARGARET LONGSTAFF 
‘Murrayfield’, Roslin Glen, Rosh, 
Midlofkian EH25 9PX, U.K. 
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Dear Sir 
Re: Ventilation in a Birmingham inten- 
sive care unit 1993-1995: outcome 
for patients with chronic obstructive 
pulmonary disease 
The report by Hill et al. (Respir Med 1998; 92: 156161) 
makes for depressing reading and will reinforce the preju- 
dice in the U.K. against intubation and ventilation in acute 
exacerbations of COPD. In a retrospective study, lack of 
medical documentation should not be taken, necessarily, to 
indicate that treatment options were not discussed with 
patients or relatives. Furthermore, what is the evidence that 
this discussion would limit the demand for ICU admission? 
We advocate discussion about the use of mechanical venti- 
lation with patients between exacerbations but recognize 
the difficulty of neutrality in this, especially in the acute 
situation. 
How many of the patients in Dr Hill’s series were 
admitted from the ward having deteriorated with medical 
therapy? Was admission delayed too long leading to an 
increase in mortality (l)? The value of non-invasive venti- 
lation (NIV) is to avoid the morbidity and mortality of 
intubation (2), yet this was only attempted in two of the 
46 cases. More pertinently, NIV may enable early extuba- 
tion (3). The finding that ICU stay was longer in the 
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